Notice Information
Notice Title
NHS England South East - Diabetic Eye Screening Programmes (DESP) across the South East
Notice Description
NHS England South East (NHSE) sought to commission a Provider(s) which had the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. The procurement was divided into 5 lots within the South East as follows: Lot 1: Kent and Medway (ICB footprint) Lot 2: Surrey Heartlands (ICB footprint) Lot 3: Hampshire and IOW (ICB footprint) Lot 4: Berkshire (Local Authority) and Frimley (ICB footprint) Lot 5: Oxfordshire and Buckinghamshire (Local Authority footprint) Providers were able to bid for one or all Lots. Contracts are for a term of 5 years, with the option to extend for up to a further 3 years. Services are planned to commence from 1st April 2025. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This should be achieved by delivering an evidence-based service that: * focuses on improving uptake, reducing inequalities, and improving outcomes * is accessible across all service elements * is engaging, and integrated, working effectively with service users and stakeholders to ensure seamless and high-quality care * is safe, effective, and high quality, with robust processes along the pathway * embed a culture of quality, improvement, and learning * is well-led, managed, and staffed There are three key elements of service delivery, namely: * routine digital screening - from 2025 and 2026, all eligible patients are to be managed on 12- or 24-month intervals * digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required * slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g., those having cataracts) Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance. The total contract values for the 5 year initial term were advertised as follows: Lot 1: Kent and Medway - PS17,755,303 Lot 2: Surrey Heartlands - PS8,084,825 Lot 3: Hampshire and IOW - PS16,695,800 Lot 4: Berkshire and Frimley - PS11,311,121 Lot 5: Oxfordshire and Buckinghamshire - PS9,927,015 This notice serves as an intention to award a contract under the competitive process of the Provider Selection Regime (PSR). This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.
Lot Information
Kent and Medway
NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 1 covers Kent and Medway and has an eligible population of around 124,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Options: The Contract can be extended for up to a further 3 years.
Surrey HeartlandsNHS England South East (NHSE SE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 2 covers Surrey Heartlands and has an eligible population of around 56,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Options: The Contract can be extended for up to a further 3 years.
Hampshire and Isle of WightNHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 3 covers the Hampshire and Isle of Wight ICB area and has an eligible population of around 117,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Options: The Contract can be extended for up to a further 3 years.
Berkshire & FrimleyNHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 4 covers all of Berkshire and the Frimley ICB area and has an eligible population of around 79,000. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Options: The Contract can be extended for up to a further 3 years.
Oxfordshire and BuckinghamshireNHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 5 covers the whole of Buckinghamshire and Oxfordshire and has an eligible population of around 69,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.
Options: The contract can be extended for up to a further 3 years.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-042d4e
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/034056-2024
- Current Stage
- Award
- All Stages
- Planning, Tender, Award
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85100000 - Health services
Notice Value(s)
- Tender Value
- £63,774,064 £10M-£100M
- Lots Value
- £63,774,064 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £60,397,774 £10M-£100M
Notice Dates
- Publication Date
- 22 Oct 20241 years ago
- Submission Deadline
- 5 Jun 2024Expired
- Future Notice Date
- 31 Mar 2024Expired
- Award Date
- 22 Sep 20241 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Not specified
- Contact Email
- scwcsu.procurement@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 8UG
- Post Town
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI45 Lambeth
- Delivery Location
- TLJ South East (England), TLJ1 Berkshire, Buckinghamshire and Oxfordshire, TLJ2 Surrey, East and West Sussex, TLJ3 Hampshire and Isle of Wight, TLJ4 Kent
-
- Local Authority
- Lambeth
- Electoral Ward
- Waterloo & South Bank
- Westminster Constituency
- Vauxhall and Camberwell Green
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-042d4e-2024-10-22T09:27:08+01:00",
"date": "2024-10-22T09:27:08+01:00",
"ocid": "ocds-h6vhtk-042d4e",
"description": "The decision to award this contract in line with the Competitive Process was based on evaluation against the basic selection criteria (in the form of a Selection Questionnaire), which was assessed on a pass/fail basis, the PSR 5 key criteria, plus staffing and mobilisation, which were assessed on a 0-4 scale, with the below weightings. Several tender questions were asked under each of the key criteria. - Quality and Innovation: 38% - Value: 5% - Integration, Collaboration and Service Sustainability: 19% - Improving Access, Reducing Health Inequalities, and Facilitating Choice: 15% - Social Value: 13% - Staffing and mobiliation: 10% The provider(s) selected for award have been chosen as they passed the basic selection criteria and were the highest scoring bidder overall, against the key criteria. After conducting a thorough Competitive Process, taking into account the key criteria and applying the basic selection criteria, NHS England South East is content that the provider's bids sufficiently met the key criteria and thus can proceed to contract award under the Health Care Services (Provider Selection Regime) Regulations 2023. The evaluation panel consisted of representatives from NHS England South East, including Commissioning, Screening & Immunisations, Finance, Human Resources, and Nursing & Quality. Award decisions have been recommended by the Head of Public Health Commissioning for Hampshire & Thames Valley (NHSE SE), and the Senior Public Health Commissioning Manager (NHSE SE). Award decisions have been made by key members of the South East Regional Executive Team (SERET), namely, the South East Regional Director (also Chair) and the Regional Director of Commissioning for the South East. There were two potential declarations of conflict of interest made via the conflict of interest process and recorded accordingly; these were not decision makers. Conflicts were appropriately managed, with one personnel being removed from the process. The other conflict recorded, upon review, was not deemed as an actual (or perceived conflict). This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight Monday 21st October. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners. Written representations should be sent to scwcsu.procurement@nhs.net",
"initiationType": "tender",
"tender": {
"id": "C253273",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS England South East - Diabetic Eye Screening Programmes (DESP) across the South East",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"mainProcurementCategory": "services",
"description": "NHS England South East (NHSE) sought to commission a Provider(s) which had the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. The procurement was divided into 5 lots within the South East as follows: Lot 1: Kent and Medway (ICB footprint) Lot 2: Surrey Heartlands (ICB footprint) Lot 3: Hampshire and IOW (ICB footprint) Lot 4: Berkshire (Local Authority) and Frimley (ICB footprint) Lot 5: Oxfordshire and Buckinghamshire (Local Authority footprint) Providers were able to bid for one or all Lots. Contracts are for a term of 5 years, with the option to extend for up to a further 3 years. Services are planned to commence from 1st April 2025. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This should be achieved by delivering an evidence-based service that: * focuses on improving uptake, reducing inequalities, and improving outcomes * is accessible across all service elements * is engaging, and integrated, working effectively with service users and stakeholders to ensure seamless and high-quality care * is safe, effective, and high quality, with robust processes along the pathway * embed a culture of quality, improvement, and learning * is well-led, managed, and staffed There are three key elements of service delivery, namely: * routine digital screening - from 2025 and 2026, all eligible patients are to be managed on 12- or 24-month intervals * digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required * slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g., those having cataracts) Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance. The total contract values for the 5 year initial term were advertised as follows: Lot 1: Kent and Medway - PS17,755,303 Lot 2: Surrey Heartlands - PS8,084,825 Lot 3: Hampshire and IOW - PS16,695,800 Lot 4: Berkshire and Frimley - PS11,311,121 Lot 5: Oxfordshire and Buckinghamshire - PS9,927,015 This notice serves as an intention to award a contract under the competitive process of the Provider Selection Regime (PSR). This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.",
"value": {
"amount": 63774064,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 1 covers Kent and Medway and has an eligible population of around 124,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.",
"status": "cancelled",
"title": "Kent and Medway",
"value": {
"amount": 17755303,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 2880
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"awardCriteria": {
"criteria": [
{
"name": "Quality and Innovation",
"type": "quality",
"description": "38.00%"
},
{
"name": "Integration, Collaboration and Service Sustainability",
"type": "quality",
"description": "19.00%"
},
{
"name": "Improving access and facilitating choice",
"type": "quality",
"description": "15.00%"
},
{
"name": "Social Value",
"type": "quality",
"description": "13.00%"
},
{
"name": "Staffing and Mobilisation",
"type": "quality",
"description": "10.00%"
},
{
"name": "Value",
"type": "quality",
"description": "5.00%"
},
{
"name": "Financial Model Template (FMT)",
"type": "cost",
"description": "Pass/ Fail"
}
]
},
"options": {
"description": "The Contract can be extended for up to a further 3 years."
}
},
{
"id": "2",
"title": "Surrey Heartlands",
"description": "NHS England South East (NHSE SE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 2 covers Surrey Heartlands and has an eligible population of around 56,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.",
"value": {
"amount": 8084825,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 2880
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Quality and Innovation",
"type": "quality",
"description": "38.00%"
},
{
"name": "Integration, Collaboration and Service Sustainability",
"type": "quality",
"description": "19.00%"
},
{
"name": "Improving access and facilitating choice",
"type": "quality",
"description": "15.00%"
},
{
"name": "Social Value",
"type": "quality",
"description": "13.00%"
},
{
"name": "Staffing and Mobilisation",
"type": "quality",
"description": "10.00%"
},
{
"name": "Finance",
"type": "quality",
"description": "5.00%"
},
{
"name": "FMT",
"type": "cost",
"description": "Pass/ Fail"
}
]
},
"options": {
"description": "The Contract can be extended for up to a further 3 years."
}
},
{
"id": "3",
"title": "Hampshire and Isle of Wight",
"description": "NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 3 covers the Hampshire and Isle of Wight ICB area and has an eligible population of around 117,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.",
"value": {
"amount": 16695800,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 2880
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Quality and Innovation",
"type": "quality",
"description": "38.00%"
},
{
"name": "Integration, Collaboration and Service Sustainability",
"type": "quality",
"description": "19.00%"
},
{
"name": "Improving access and facilitating choice",
"type": "quality",
"description": "15.00%"
},
{
"name": "Social Value",
"type": "quality",
"description": "13.00%"
},
{
"name": "Staffing and Mobilisation",
"type": "quality",
"description": "10.00%"
},
{
"name": "Value",
"type": "quality",
"description": "5.00%"
},
{
"name": "Financial Model Template (FMT)",
"type": "cost",
"description": "Pass/ Fail"
}
]
},
"options": {
"description": "The Contract can be extended for up to a further 3 years."
}
},
{
"id": "4",
"title": "Berkshire & Frimley",
"description": "NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 4 covers all of Berkshire and the Frimley ICB area and has an eligible population of around 79,000. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.",
"value": {
"amount": 11311121,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 2880
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Quality and Innovation",
"type": "quality",
"description": "38.00%"
},
{
"name": "Integration, Collaboration and Service Sustainability",
"type": "quality",
"description": "19.00%"
},
{
"name": "Improving access and facilitating choice",
"type": "quality",
"description": "15.00%"
},
{
"name": "Social Value",
"type": "quality",
"description": "13.00%"
},
{
"name": "Staffing and Mobilisation",
"type": "quality",
"description": "10.00%"
},
{
"name": "Value",
"type": "quality",
"description": "5.00%"
},
{
"name": "Financial Model Template (FMT)",
"type": "cost",
"description": "Pass/ Fail"
}
]
},
"options": {
"description": "The Contract can be extended for up to a further 3 years."
}
},
{
"id": "5",
"title": "Oxfordshire and Buckinghamshire",
"description": "NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. Lot 5 covers the whole of Buckinghamshire and Oxfordshire and has an eligible population of around 69,000 people. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: * Identifies the eligible population and ensured effective delivery with maximum coverage * Is safe, effective, high quality, externally and independently monitored, and quality assured * Leads to earlier detection, appropriate referral, effective treatment, and improved outcomes * Is delivered and supported by suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participated in recognised ongoing continuing medical education (CME), continuous professional development (CPD), and quality assurance (QA) schemes * Has audit embedded in the service * Works effectively with other stakeholders to ensure the care pathway was smooth and efficient. There are three key elements of service delivery, namely: * Routine digital screening - from 2025 and 2026, all eligible patients are managed on 12- or 24-month intervals for routine diabetic eye screening. * Digital surveillance, where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required. * Slit lamp bio-microscopy (SLB) for those individuals where normal photography are inappropriate (e.g., those having cataracts). The Contract is planned to commence on 1st April 2025, for an initial term of 5 years, with the option to extend for a further 3 years.",
"value": {
"amount": 9927015,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 2880
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Quality and Innovation",
"type": "quality",
"description": "38.00%"
},
{
"name": "Integration, Collaboration and Service Sustainability",
"type": "quality",
"description": "19.00%"
},
{
"name": "Improving access and facilitating choice",
"type": "quality",
"description": "15.00%"
},
{
"name": "Social Value",
"type": "quality",
"description": "13.00%"
},
{
"name": "Staffing and Mobilisation",
"type": "quality",
"description": "10.00%"
},
{
"name": "Value",
"type": "quality",
"description": "5.00%"
},
{
"name": "Financial Model Template (FMT)",
"type": "cost",
"description": "Pass/ Fail"
}
]
},
"options": {
"description": "The contract can be extended for up to a further 3 years."
}
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKJ"
},
{
"region": "UKJ4"
},
{
"region": "UKJ4"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKJ2"
},
{
"region": "UKJ2"
}
],
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKJ3"
},
{
"region": "UKJ3"
}
],
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKJ"
},
{
"region": "UKJ4"
}
],
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKJ1"
},
{
"region": "UKJ1"
}
],
"relatedLot": "5"
}
],
"communication": {
"futureNoticeDate": "2024-04-01T00:00:00+01:00"
},
"coveredBy": [
"GPA"
],
"amendments": [
{
"id": "1",
"unstructuredChanges": [
{
"oldValue": {
"text": "If you are interested in these services, please register on the e-procurement system, Atamis (details at the end of this notice), and submit a completed provider market engagement questionnaire by 12 noon on 2nd February 2024."
},
"newValue": {
"text": "If you are interested in these services, please register on the e-procurement system, Atamis (details at the end of this notice), and submit a completed provider market engagement questionnaire by 12 noon on 9th February 2024."
},
"where": {
"section": "II.1.4",
"label": "Short Description"
}
}
]
},
{
"id": "2",
"description": "The contract award date for these contracts is 22nd October 2024. The contract period for these contracts is 5 years, the contract start date is 1st April 2025 and the contract end date is 31st March 2030. The parties will also have the option to extend the contract for a further 3 years, with mutual agreement The total awarded contract value of the contract are as follows: Lot 1 - Kent and Medway: PS16,815,307 Lot 2 - Surrey: PS7,656,783 Lot 3 - HIOW: PS15,811,901 Lot 4 - Berkshire & Frimley: PS10,712,264 Lot 5 - Oxfordshire & Buckinghamshire: PS9,401,519 Overall total contract value: PS60,397,774 This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using the competitive process."
}
],
"submissionMethod": [
"written"
],
"selectionCriteria": {
"criteria": [
{
"type": "technical",
"description": "Details regarding the selection criteria are described within the ITT Bidder Instructions document. This includes details on the economic and financial standing tests that will be managed including the 'pass' score.",
"minimum": "Minimum level(s) of standards possibly required: (no more than 10,000 characters)",
"appliesTo": [
"supplier"
]
}
]
},
"documents": [
{
"id": "economic",
"documentType": "economicSelectionCriteria"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"tenderPeriod": {
"endDate": "2024-06-05T12:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 180
}
},
"awardPeriod": {
"startDate": "2024-06-05T12:15:00+01:00"
},
"bidOpening": {
"date": "2024-06-05T12:15:00+01:00"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-FTS-68694",
"name": "NHS England",
"identifier": {
"legalName": "NHS England",
"noIdentifierRationale": "notOnAnyRegister"
},
"address": {
"streetAddress": "Wellington House, 133-155 Waterloo Road",
"locality": "London",
"region": "UKI",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "scwcsu.procurement@nhs.net",
"url": "https://health-family.force.com/s/Welcome"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/south-east/",
"buyerProfile": "https://health-family.force.com/s/Welcome",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-110808",
"name": "NHS England",
"identifier": {
"legalName": "NHS England",
"noIdentifierRationale": "notOnAnyRegister"
},
"address": {
"streetAddress": "Premier House, 60 Caversham Road,",
"locality": "Reading",
"region": "UKK11",
"postalCode": "RG1 7EB",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "scwcsu.procurement@nhs.net",
"url": "https://health-family.force.com/s/Welcome"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "https://www.england.nhs.uk",
"buyerProfile": "https://health-family.force.com/s/Welcome",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-110809",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"locality": "Reading",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "scwcsu.procurement@nhs.net"
},
"roles": [
"reviewBody"
]
},
{
"id": "GB-FTS-126281",
"name": "NHS England",
"identifier": {
"legalName": "NHS England",
"noIdentifierRationale": "notOnAnyRegister"
},
"address": {
"streetAddress": "Wellington House, 133-135 Waterloo Road",
"locality": "London",
"region": "UKI",
"postalCode": "SE18UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "scwcsu.procurement@nhs.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk",
"buyerProfile": "https://health-family.force.com/s/Welcome",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited",
"identifier": {
"legalName": "InHealth Intelligence Limited",
"id": "03257228",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Beechwood Hall. Kingsmead Road",
"locality": "High Wycombe",
"region": "UKJ1",
"postalCode": "HP11 1JL",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7114",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-126281",
"name": "NHS England"
},
"language": "en",
"awards": [
{
"id": "032257-2024-1-1",
"relatedLots": [
"1"
],
"title": "Kent and Medway",
"status": "active",
"suppliers": [
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited"
}
]
},
{
"id": "032257-2024-2-2",
"relatedLots": [
"2"
],
"title": "Surrey Heartlands",
"status": "active",
"suppliers": [
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited"
}
]
},
{
"id": "032257-2024-3-3",
"relatedLots": [
"3"
],
"title": "Hampshire and Isle of Wight",
"status": "active",
"suppliers": [
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited"
}
]
},
{
"id": "032257-2024-4-4",
"relatedLots": [
"4"
],
"title": "Berkshire",
"status": "active",
"suppliers": [
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited"
}
]
},
{
"id": "032257-2024-5-5",
"relatedLots": [
"5"
],
"title": "Oxfordshire and Buckinghamshire",
"status": "active",
"suppliers": [
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited"
}
]
}
],
"contracts": [
{
"id": "032257-2024-1-1",
"awardID": "032257-2024-1-1",
"title": "Kent and Medway",
"status": "active",
"value": {
"amount": 16815307,
"currency": "GBP"
},
"dateSigned": "2024-09-23T00:00:00+01:00"
},
{
"id": "032257-2024-2-2",
"awardID": "032257-2024-2-2",
"title": "Surrey Heartlands",
"status": "active",
"value": {
"amount": 7656783,
"currency": "GBP"
},
"dateSigned": "2024-09-23T00:00:00+01:00"
},
{
"id": "032257-2024-3-3",
"awardID": "032257-2024-3-3",
"title": "Hampshire and Isle of Wight",
"status": "active",
"value": {
"amount": 15811901,
"currency": "GBP"
},
"dateSigned": "2024-09-23T00:00:00+01:00"
},
{
"id": "032257-2024-4-4",
"awardID": "032257-2024-4-4",
"title": "Berkshire",
"status": "active",
"value": {
"amount": 10712264,
"currency": "GBP"
},
"dateSigned": "2024-09-23T00:00:00+01:00"
},
{
"id": "032257-2024-5-5",
"awardID": "032257-2024-5-5",
"title": "Oxfordshire and Buckinghamshire",
"status": "active",
"value": {
"amount": 9401519,
"currency": "GBP"
},
"dateSigned": "2024-09-23T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 3
},
{
"id": "2",
"measure": "bids",
"relatedLot": "2",
"value": 3
},
{
"id": "3",
"measure": "bids",
"relatedLot": "3",
"value": 3
},
{
"id": "4",
"measure": "bids",
"relatedLot": "4",
"value": 3
},
{
"id": "5",
"measure": "bids",
"relatedLot": "5",
"value": 3
}
]
}
}